Transmissible spongiform encephalopathies (Prion diseases) - Molecular biology and in vitro models;Ubertragbare spongiforme enzephalopathien (Prion-krankheiten) - Molekulare grundlagen und in-vitro-modelle

Wiener Medizinische Wochenschrift

Volumn 148, Issue 4, 1998, Pages 67-73

  Kretzschmar, H ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; PRION PROTEIN;

ARTICLE; CONFORMATIONAL TRANSITION; GENE MUTATION; HUMAN; MICROGLIA; MOLECULAR BIOLOGY; NEUROTOXICITY; PRION; PRION DISEASE; PROTEIN STRUCTURE; ANIMAL; BRAIN; CHROMOSOME 20; DISEASE TRANSMISSION; GENETIC POLYMORPHISM; GENETICS; NUCLEOTIDE SEQUENCE; REVIEW; VIROLOGY;

ANIMALS; BRAIN; CHROMOSOMES, HUMAN, PAIR 20; DNA MUTATIONAL ANALYSIS; HUMANS; MICROGLIA; POLYMORPHISM, GENETIC; PRION DISEASES; PRIONS;

EID: 0031595526     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (93)

1. Bessen RA, Kocisko DA, Raymond GJ, Nandan S, Lansbury PT, Caughey B: Non-genetic propagation of strain-specific properties of serapie prion protein. Nature 1995;375:698-700.
2. Bogumil T, Jacobsen T, Windl O, Giese A, Beuche W, Zerr I, Räcker S, Grosche S, Szudra A, Poser S, Weber T, Kretzschmar HA: Cerebellar changes in sporadic Creutzfeldt-Jakob disease: A synopsis of clinical, histological, immunohistochemical, and genetic data. Eur J Pathol 1995;1-3.
3. Borehelt DR, Scott D, Taraboulos A, Stahl N, Prusiner SB: Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells. J Cell Biol 1990;110:743-752.
4. Borchelt DR, Koliatsos VE, Guarnieri M, Pardo CA, Sisodia SS, Price DL: Rapid anterograde axonal transport of the cellular prion glycoprotein in the peripheral and central nervous system. J Biol Chem 1994;269:14711-14714.
5. Brandner S, Isenmann S, Raeber A, Fischer M, Sailer A, Kobayashi Y, Marino S, Weissmann C, Aguzzi A: Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 1996;379:339-343.
6. Brown DR, Schmidt B, Kretzschmar HA: Role of microglia and host prion protein in neurotoxicity of prion protein fragment. Nature 1996;380:345-347.
7. Brown DR, Quin K, Herms JW, Madlung A, Manson J, Strome R, Fraser P, Kruck T, Bohlen Av, Schulz-Schaeffer W, Giese A, Westaway D, Kretzschmar H: The cellular prion protein binds copper in vivo. Nature 1997;390:684-687.
8. Brown DR, Schulz-Schaeffer WJ, Schmidt B, Kretzschmar HA: Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity. Exp Neurol 1997;146:104-112.
9. Brown P, Cervenáková L, Goldfarb LG, McCombie WR, Rubenstein, Will RG, Pocchiari M, Martinez Lage JF, Scalici C, Masullo C, Graupera G, Ligan J, Gajdusek DC: latrogenic Creutzfeldt-Jakob disease: an example of the interplay between ancient genes and modern medicine. Neurology 1994;44:291-293.
10. Buja LM, Eigenbrodt ML, Eigenbrodt EH: Apoptosis and necrosis. Basic types and mechanisms of cell death. Arch Pathol Lab Med 1993;117:1208-1214.
11. Büeler H, Fischer M, Lang Y, Bluethmann H, Lipp H-P, DeArmond SJ, Prusiner SB, Aguet M, Weissmann C: Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 1992;356:577-582.
12. Büeler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, Weissmann C: Mice devoid of PrP are resistant to scrapie. Cell 1993;73:1339-1348.
13. Caughey B, Raymond GJ: The scrapie-associated form of PrP is made from a cell surface precursor that is both protease-sensitive and phospholipase-sensitive. J Biol Chem 1991;266:18217-18223.
14. Caughey BW, Dong A, Bhat KS, Ernst D, Hayes SF, Caughey WS: Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry 1991;30:7672-7679.
15. + currents. Neurosci Lett 1996;209:49-52.
16. Collinge J, Palmer MS, Dryden AJ: Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease. Lancet 1991;337:1441-1442.
17. Collinge J, Whittington MA, Sidle KCL, Smith CJ, Palmer MS, Clarke AR, Jefferys JGR: Prion protein is necessary for normal synaptic function. Nature 1994;370:295-297.
18. Collinge J, Palmer MS, Sidle KCL, Hill AF, Gowland I, Meads J, Asante E, Bradley R, Doey LJ, Lantos PL: Unaltered susceptibility to BSE in transgenic mice expressing human prion protein. Nature 1995;370:779-783.
19. Collinge J, Sidle KCL, Meads J, Ironside J, Hill AF: Molecular analysis of prion strain variation and the aetiology of "new variant" CJD. Nature 1996;383:685-690.
20. Creutzfeldt HG: Über eine eigenartige herdförmige Erkrankung des Zentralnervensystems. Z Ges Neurol Psychiatr 1920;57:1-18.
21. Cuillé J, Chelle P-L: La maladie dite tremblante du mouton cst-elle inoculable? C R Acad Sci 1936;(III)203:1552-1554.
22. DeSilva R, Ironside JW, McCardle L, Esmonde T, Bell J, Will R, Windl O, Dempster M, Estibeiro P, Lathe R: Neuropathological phenotype and 'prion protein' genotype correlation in sporadic Creutzfeldt-Jakob disease. Neurosci Lett 1994;179:50-52.
23. Deslys J-P, Marcé D, Dormont D: Similar genetic susceptibility in iatrogenic and sporadic Creutzfeldt-Jakob disease. J Gen Virol 1994;75:23-27.
24. Dlouhy SR, Hsiao K, Farlow MR, Foroud T, Conneally PM, Johnson P, Prusiner SB, Hodes ME, Ghetti B: Linkage of Indiana kindred of Gerstmann-Straussler-Scheinker disease to prion protein gene. Nature Genet 1992;1:64-67.
25. Forloni G, Angeretti N, Chicsa R, Monzani E, Salmona M, Bugiani O, Tagliavini F: Neurotoxicity of a prion protein fragment. Nature 1993;362:543-546.
26. C) in synaptic boutons of normal hamster hippocampus. C R Acad Sci Paris, Sciences de la vie / Life sciences 1995;318:339-344.
27. Fraser J, Jeffrey M, Halliday W, Fowler N, Goodsir C, Brown D: Early loss of neurons and axon terminals in scrapie-affected mice revealed by morphometry and immunocytochemistry. Mol Chem Neuropathol 1995;24:245-249.
28. Gabriel JM, Oesch B, Kretzschmar HA, Scott M, Prusiner SB: Molecular cloning of a candidate chicken prion protein. Proc Natl Acad Sci USA 1992;89:9097-9101.
29. Gajdusek DC, Gibbs CJ, Alpers M: Experimental transmission of a kuru-like syndrome to chimpanzees. Nature 1966;209:794-796.
30. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
31. Gold R, Schmied M, Rothe G, Zischler H, Breitschopf H, Wekerle H, Lassmann H: Detection of DNA fragmentation in apoptosis: application of in situ nick translation to cell culture systems and tissue sections. J Histochem Cytochem 1993;41:1023-1030.
32. Goldfarb LG, Petersen RB, Tabaton M, Brown P, Leblanc AC, Montagna P, Cortelli P, Julien J, Vital C, Pendelbury WW, Haltia M, Wills PR, Hauw JJ, McKeever PE, Monari L, Schrank B, Swergold GD, Autilio-Gambetti L, Gajdusek DC, Lugaresi E, Gambetti P: Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science 1992;258:806-808.
33. Goldmann W, Hunter N, Foster JD, Salbaum JM, Beyreuther K, Hope J: Two alleles of a neural protein linked to scrapie in sheep. Proc Natl Acad Sci USA 1990;87:2476-2480.
34. Goldmann W, Hunter N, Martin T, Dawson M, Hope J: Different forms of the bovine PrP gene have five or six copies of a short, G-C-rich element within the protein-coding exon. J Gen Virol 1991;72:201-204.
35. Hadlow WJ: Scrapie and kuru. Lancet 1959;II:289-290.
36. Herms JW, Kretzschmar HA, Titz S, Keller BU: Patch-clamp analysis of synaptic transmission to cerebellar Purkinje cells of prion protein knockout mice. Eur J Neurosci 1995;7:2508-2512.
37. Hornemann S, Korth C, Oesch B, Riek R, Wider G, Wüthrich K, Glockshuber R: Recombinant full-length murine prion protein, mPrP(23-231): purification and spectroscopic characterization. FEBS Lett.
38. Hsiao K, Scott M, Foster D, Groth DF, DeArmond SJ, Prusiner SB: Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science 1990;250:1587-1590.
39. Hsiao K, Groth D, Scott M, Yang S-L, Serban H, Raff D, Foster D, Torchia M, DeArmond SJ, Prusiner SB: Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein. Proc Natl Acad Sci USA 1994;91:9126-9130.
40. Jakob A: Über eigenartige Erkrankungen des Zentralnervensystems mit bemerkenswertem anatomischem Befunde (spastische Pseudosklerosc-Encephalomyelopathie mit disseminierten Degenerationsherden). Dtsch Z Nervenheilk 1921;70:132-146.
41. Jakob A: Spastische Pseudosklerose. In Jakob A (ed): Die extrapyramidalen Erkrankungen. Berlin: Springer, pp. 215-245.
42. Jarrett JT, Lansbury PT: Seeding one-dimensional crystallization of amyloid - a pathogenic mechanism in Alzheimer's disease and scrapie. Cell 1993;73:1055-1058.
43. Jeffrey M, Fraser JR, Halliday WG, Fowler N, Goodsir CM, Brown DA: Early unsuspected neuron and axon terminal loss in scrapie-in-fected mice revealed by morphometry and immunocytochemistry. Neuropathol Appl Neurobiol 1995;21:41-49.
44. Kellings K, Meyer N, Mirenda C, Prusiner SB, Riesner D: Further analysis of nucleic acids in purified scrapie prion preparations by improved return refocusing gel electrophoresis. J Gen Virol 1992;73:1025-1029.
45. Kerr JFR, Wyllie AH, Currie AR: Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-257.
46. Kocisko DA, Come JH, Priola SA, Chesebro B, Raymond GJ, Lansbury PT, Caughey B: Cell-free formation of protease-resistant prion protein. Nature 1994;370:471-473.
47. Kocisko DA, Priola SA, Raymond GJ, Chesebro, B, Lansbury PT, Caughey B: Species specificity in the cell-free conversion of prion protein to protease-resistant forms: A model for the scrapie species barrier. Proc Natl Acad Sci USA 1995;92:3923-3927.
48. Kretzschmar HA, Prusiner SB, Stowring LE, DeArmond SJ: Scrapie prion proteins are synthesized in neurons. Am J Pathol 1986;122:1-5.
49. Kretzschmar HA, Stowring LE, Westaway D, Stubblebine WH, Prusiner SB, DeArmond SJ: Molecular cloning of a human prion protein cDNA. DNA 1986;5:315-324.
50. Kretzschmar HA, Neumann M, Stavrou D: Codon 178 mutation of the human prion protein gene in a German family (Backer family): sequencing data from 72 year-old celloidin-embedded brain tissue. Acta Neuropathol (Berl) 1995;89:96-98.
51. Laplanche JL, Delasnerie-Lauprêtre N, Brandel JP, Chatelain J, Beaudry P, Alperovitch A, Launay J-M: Molecular genetics of prion diseases in France. Neurology 1994;44:2347-2351.
52. Lledo PM, Tremblay P, DeArmond SJ, Prusiner SB, Nicoll RA: Mice deficient for prion protein exhibit normal neuronal excitability and synaptic transmission in the hippocampus. Proc Natl Acad Sci USA 1996;93:2403-2407.
53. Manson J, West JD, Thomson V, McBride P, Kaufman MH, Hope J: The prion protein gene: a role in mouse embryogenesis? Development 1992;115:117-122.
54. Manson JC, Clarke AR, Hooper ML, Aitchison L, McConnell I, Hope J: 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol Neurobiol 1994;8:121-127.
55. Manson JC, Clarke AR, McBride PA, McConnell I, Hope J: PrP gene dosage determines the timing but not the final intensity or distribution of lesions in scrapie pathology. Neurodegeneration 1994;3:331-340.
56. Manson JC, Hope J, Clarke AR, Johnston A, Black C, MacLeod N: PrP gene dosage and long term potentiation. Neurodegeneration 1995;4:113-115.
57. Masters CL, Gajdusek DC, Gibbs CJ jr: Creutzfeldt-Jakob disease virus isolations from the Gerstmann-Sträussler syndrome. With an analysis of the various forms of amyloid plaque deposition in the virus-induced spongiform encephalopathies. Brain 1981;104:559-588.
58. Meggendorfer F: Klinische und genealogische Beobachtungen bei einem Fall von spastischer Pseudosklerose. Z Ges Neurol Psychiatr 1930;128:337-341.
59. Miyazono M, Kitamoto T, Dohura K, Iwaki T, Tateishi J: Creutzfeldt-Jakob disease with codon-129 polymorphism (valine). A comparative study of patients with codon-102 point mutation or without mutations. Acta Neuropathol (Berl) 1992;84:349-354.
60. Moser M, Colello RJ, Pott U, Oesch B: Developmental expression of the prion protein gene in glial cells. Neuron 1995;14:509-517.
61. Müller WEG, Ushijima H, Schroder HC, Forrest JMS, Schatton WFH, Rytik PG, Heffner-Lauc M: Cytoprotective effect of NMDA receptor antagonists on prion protein (PrionSc)-induced toxicity in rat cortical cell cultures. Eur J Pharmacol 1993;246:261-267.
62. Oesch B, Westaway D, Wälchli M, McKinley MP, Kent SBH, Aebersold R, Barry RA, Tempst P, Teplow DB, Hood LE, Prusiner SB, Weissmann C: A cellular gene encodes scrapie PrP 27-30 protein. Cell 1985;40:735-746.
63. Palmer MS, Dryden AJ, Hughes JT, Collinge J: Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 1991;352:340-342.
64. Pan KM, Stahl N, Prusiner SB: Purification and properties of the cellular prion protein from Syrian hamster brain. Protein Sci 1992;1:1343-1352.
65. Pan KM, Baldwin M, Nguyen J, Gasset M, Serban A, Groth D, Mehlhorn I, Huang Z, Fletterick RJ, Cohen FE, Prusiner SB: Conversion of a-helices into ß-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci USA 1993;90:10962-10966.
66. Parchi P, Castellani R, Capellari S, Ghetti B, Young K, Chen SG, Farlow M, Dickson DW, Sima AAF, Trojanowsky JQ, Petersen RB, Gambetti P: Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 1996;39:767-778.
67. Parchi P, Capellari S, Chen SG, Petersen RB, Gambetti P, Kopp N, Brown P, Kitamoto T, Tateishi J, Giese A, Kretzschmar H: Typing prion isoforms. Nature 1997;386:232-233.
68. Poulter M, Baker HF, Frith CD, Leach M, Lofthouse R, Ridley RM, Shah T, Owen F, Collinge J, Brown J, et al: Inherited prion disease with 144 base pair gene insertion. 1. Genealogical and molecular studies. Brain 1992;115:675-686.
69. Prusiner SB: Novel proteinaceous infectious particles cause scrapie. Science 1982;216:136-144.
70. Prusiner SB: Scrapie prions. Annu Rev Microbiol 1989;43:345-374.
71. Prusiner SB, Scott M, Foster D, Pan K-M, Groth D, Mirenda C, Torchia M, Yang S-L, Serban D, Carlson GA, Hoppe PC, Westaway D, DeArmond SJ: Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell 1990;63:673-686.
72. Prusiner SB: Molecular biology of prion diseases. Science 1991;252:1515-1522.
73. Puckett C, Concannon P, Casey C, Hood L: Genomic structure of the human prion protein gene. Am J Hum Genet 1991;49:320-329.
74. Race RE, Priola SA, Bessen RA, Ernst D, Dockter J, Rall GF, Mucke L, Chesebro B, Oldstone MBA: Neuron-specific expression of a hamster prion protein minigene in transgenic mice induces susceptibility to hamster scrapie agent. Neuron 1995;15:1183-1191.
75. Riek R, Hornemann S, Wider G, Billeter M, Glockshuber R, Wüthrich K: NMR structure of the mouse prion protein domain PrP (121-231). Nature 1996;382:180-182.
76. Riek R, Hornemann S, Wider G, Glockshuber R, Wüthrich K: NMR characterization of the full-lenth recombinant murine prion protein. mPrP(23-231). FEBS Lett 1997;413:282-288.
77. Sakaguchi S, Katamine S, Nishida N, Moriuchi R, Shigematsu K, Sugimoto T, Nakatani A, Kataoka Y, Houtani T, Shirabe S, Okada H, Hasegawa S, Miyamoto T, Noda T: Loss of cerebellar Purkinje cells in aged mice homozygous for a disrupted PrP gene. Nature 1996;380:528-531.
78. Salvatore M, Genuardi M, Petraroli R, Masullo C, DAlessandro M, Pocchiari M: Polymorphisms of the prion protein gene in Italian patients with Creutzfeldt-Jakob disease. Hum Genetics 1994;94:375-379.
79. Schätzl HM, DaCosta M, Taylor L, Cohen FE, Prusiner SB: Prion protein gene variation among primates. J Mol Biol 1995;245:362-374.
80. Scott M, Foster D, Mirenda C, Serban D, Coufal F, Wälchli M, Torchia M, Groth D, Carlson G, DeArmond SJ, Westaway D, Prusiner SB: Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell 1989;59:847-857.
81. Searle J, Kerr JFR, Bishop CJ: Necrosis and apoptosis: distinct modes of cell death with fundamentally different significance. Path Ann 1982;17:229-259.
82. Shyng SL, Huber MT, Harris DA: A prion protein cycles between the cell surface and an endocytic compartment in cultured neuroblastoma cells. J Biol Chem 1993;268:15922-15928.
83. Sloviter RS, Dean E, Neubort S: Electron microscopic analysis of adrenalectomy-induced hippocampal granule cell degeneration in the rat: apoptosis in the adult central nervous system. J Comp Neurol 1993;330:337-351.
84. Stahl N, Borchelt DR, Hsiao K, Prusiner SB: Scrapie prion protein contains a phospatidylinositol glycolipid. Cell 1987;51:229-240.
85. Telling GC, Scott M, Mastrianni J, Gabizon R, Torchia M, Cohen FE, DeArmond SJ, Prusiner SB: Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 1995;83:79-90.
86. Telling GC, Parchi P, DeArmond SJ, Cortelli P, Montagna P, Gabizon R, Mastrianni J, Lugaresi E, Gambetti P, Prusiner SB: Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 1996;274:2079-2082.
87. Tobler I, Gaus SE, Deboer T, Achermann P, Fischer M, Rülicke T, Moser M, Oesch B, McBride PA, Manson JC: Altered circadian activity rhythms and sleep in mice devoid of prion protein. Nature 1996;380:639-642.
88. Westaway D, Cooper C, Turner S, DaCosta M, Carlson GA, Prusiner SB: Structure and polymorphism of the mouse prion protein gene. Proc Natl Acad Sci USA 1994;91:6418-6495.
89. Westaway D, DeArmond SJ, Cayetano-Canlas J, Groth D, Foster D, Yang SL, Torchia M, Carlson GA, Prusiner SB: Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins. Cell 1994;76:117-129.
90. Whatley SA, Powell JF, Politopoulou G, Campbell IC, Brammer MJ, Percy NS: Regulation of intracellular free calcium levels by the cellular prion protein. Neuroreport 1995;6:2333-2337.
91. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, Poser S, Pocchiari M, Hofman A, Smith PG: A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996;347:921-925.
92. Windl O, Dempster M, Estibeiro P, Lathe R: A candidate marsupial PrP gene reveals two domains conserved in mammalian PrP proteins. Gene 1995;159:181-186.
93. Windl O, Dempster M, Estibeiro JP, Lathe R, DeSilva R, Esmonde T, Will R, Springbett A, Campbell TA, Sidle KCL, Palmer MS, Collinge J: Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variations in the PRNP gene. Hum Genetics 1996;98:259-264.